Transcatheter closure of patent foramen ovale in older adults

Catheterization and Cardiovascular Interventions

Volumn 68, Issue 1, 2006, Pages 136-142

  Kiblawi, Fuad M ^a   Sommer, Robert J ^b   Levchuck, Sean G ^c  

^a ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

^b Columbia University ^*  (United States)

^c ST FRANCIS HOSPITAL   (United States)

Author keywords

Atrial fibrillation; Patent foramen ovale (PPO); Stroke; Transcatheter

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEVICE; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PATIENT SAFETY; PROSPECTIVE STUDY; RECURRENCE RISK; REGISTER; SINUS RHYTHM; STROKE; TRANSCATHETER CLOSURE; TRANSIENT ISCHEMIC ATTACK;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; HEADACHE; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; RESEARCH DESIGN; STROKE; TREATMENT OUTCOME;

EID: 33745768435     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20722     Document Type: Article

References (44)

1. Lechat P, Mas JL, Lascault G, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
2. Webster MW, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, Glasgow GL. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-12.
3. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-1908.
4. Devuyst G, Bogousslavsky J, Ruchat P, Jeanrenaud X, Despland PA, Regli F, Aebischer N, Karpuz HM, Castillo V, Guffi M, Sadeghi H. Prognosis after stroke followed by surgical closure of patent foramen ovale: A prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology 1996;47:1162-1166.
5. Sievert H, Babic UU, Hausdorf G, Schneider M, Hopp HW, Pfeiffer D, Pfisterer M, Friedli B, Urban P. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol 1998; 82:1405-1413.
6. Cujec B, Mainra R, Johnson DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol 1999;15:57-64.
7. Windecker S, Wahl A, Chatterjee T, Garachemani A, Eberli FR, Seiler C, Meier B. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-898.
8. Schuchlenz HW, Weihs W, Berghold A, Lechner A, Schmidt R. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. Int J Cardiol 2005;101: 77-82.
9. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461-465.
10. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology 2000;55:1172-1179.
11. Lewis RR, Hussain A, Rashed KA, Cooke RA, McNabb WR, Chambers J. Patent foramen ovale in elderly stroke patients. Int J Clin Pract 2001;55:596-598.
12. Vella MA, Sulke AN, Rodrigues CA, McNabb WR, Lewis RR. Patent foramina ovale in elderly stroke patients. Postgrad Med J 1991;67:745-746.
13. Homma S, DiTullio MR, Sacco RL, Sciacca RR, Mohr JP, PICCS Investigators. Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. Stroke 2004;35:2145-2149.
14. McMahon CJ, El Said HG, Mullins CE. Use of the transseptal puncture in transcatheter closure of long tunnel-type patent foramen ovale. Heart 2002;88:E3.
15. Braun MU, Ehrhard K, Strasser RH, Haass M. [Occlusion by catheter intervention in patent foramen ovale via additional transseptal puncture]. Z Kardiol 2002;91:659-662.
16. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005; 91:1173-1175.
17. Martin F, Sanchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King ME, Buonanno F, Demirjian Z, de Moor M, Palacios IF. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121-1126.
18. Bruch L, Parsi A, Grad MO, Rux S, Burmeister T, Krebs H, Kleber FX. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism. Single-center experience. Circulation 2002;105:2845-2848.
19. Wahl A, Windecker S, Eberli FR, Seiler C, Meier B. Percutaneous closure of patent foramen ovale in symptomatic patients. J Interv Cardiol 2001;14:203-209.
20. Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H, Haass M, Schraeder R, Strasser RH. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Peri-procedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004;25: 424-430.
21. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G. Stroke recurrence in patients with patent foramen ovale: The Lausanne Study. Lausanne Stroke with Paradoxical Embolism Study Group. Neurology 1996;46:1301-1305.
22. Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL. Patent foramen ovale: Is stroke due to paradoxical embolism? Stroke 1993;24:31-34.
23. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: Patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002;105:2625-2631.
24. Klotzsch C, Janssen G, Berlit P. Transesophageal echocardiography and contrast-TCD in the detection of a patent foramen ovale: Experiences with 111 patients. Neurology 1994;44:1603-1606.
25. Zanette EM, Mancini G, De Castro S, Solaro M, Cartoni D, Chiarotti F. Patent foramen ovale and transcranial Doppler. Comparison of different procedures. Stroke 1996;27:2251-2255.
26. Blersch WK, Draganski BM, Holmer SR, Koch HJ, Schlachetzki F, Bogdahn U, Holscher T. Transcranial duplex sonography in the detection of patent foramen ovale. Radiology 2002;225:693-699.
27. Beitzke A, Schuchlenz H, Beitzke M, Gamillscheg A, Stein HI, Zartner P. Interventional occlusion of foramen ovale and atrial septal defects after paradoxical embolism incidents. Z Kardiol 2002;91:693-700.
28. Sievert H, Horvath K, Zadan E, Krumsdorf U, Fach A, Merle H, Scherer D, Schrader R, Spies H, Nowak B, Lissmann-Jensen H. Patent foramen ovale closure in patients with transient ischemic attack/stroke. J Interv Cardiol 2001;14:261-266.
29. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, Forcier A, Dalen JE. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991;151:933-938.
30. Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med 1997;126:528-531.
31. Hung J, Landzberg MJ, Jenkins KJ, King ME, Lock JE, Palacios IF, Lang P. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000;35:1311-1316.
32. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004;43:302-309.
33. Kalman JM, Tonkin AM. Atrial fibrillation: Epidemiology and the risk and prevention of stroke. Pacing Clin Electrophysiol 1992;15:1332-1346.
34. Pezzini A, Del Zotto E, Magoni M, Costa A, Archetti S, Grassi M, Akkawi NM, Albertini A, Assanelli D, Vignolo LA, Padovani A. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke 2003;34:28-33.
35. Pollick C, Taylor D. Assessment of left atrial appendage function by transesophageal echocardiography: Implications for the development of thrombus. Circulation 1991;84:223-231.
36. Di Tullio MR, Sacco RL, Savoia MT, Sciacca RR, Homma S. Aortic atheroma morphology and the risk of ischemic stroke in a multiethnic population. Am Heart J 2000;139:329-336.
37. Cerrato P, Grasso M, Imperiale D, Priano L, Baima C, Giraudo M, Rizzuto A, Azzaro C, Lentini A, Bergamasco B. Stroke in young patients: Etiopathogenesis and risk factors in different age classes. Cerebrovasc Dis 2004;18:154-159.
38. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, Diehl L, Aurora S, Gray WA. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45:493-495.
39. Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R. Association of interatrial shunts and migraine headaches: Impact of transcatheter closure. J Am Coll Cardiol 2005;45:489-492.
40. Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 2005;45: 1213-1218. Review.
41. Di Tullio M, Sacco RL, Venketasubramanian N, Sherman D, Mohr JP, Homma S. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993;24:1020-1024.
42. Page RL, Tilsch TW, Connolly SJ, Schnell DJ, Marcello SR, Wilkinson WE, Pritchett EL, Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators. Asymptomatic or "silent" atrial fibrillation: Frequency in untreated patients and patients receiving azimilide. Circulation 2003;107:1141-1145.
43. Savelieva I, Camm AJ. Clinical relevance of silent atrial fibrillation: Prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol 2000;4:369-382.
44. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke 1996;27:1765-1769.